1. Oncoscope

    0 Comments Leave a Comment

    1-15 of 27 1 2 »
    1. Mentioned In 27 Articles

    2. 1-15 of 27 1 2 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Oncoscope


    Oncoscope, Inc. is a medical device company that develops proprietary optical imaging systems for epithelial tissues in the oral cavity, esophagus, stomach, colon, lung, cervix and bladder. These systems provide measurements of the diameter and density of cell nuclei in vivo and up to tissue depths of 500 microns.  Oncoscope was founded in June, 2006 to develop clinical applications of discoveries in the field of optical imaging pioneered by Dr. Adam Wax at the Department of Biomedical Engineering of Duke University. These discoveries are known as Angle-resolved Low Coherence Interferometry (a/LCI) and arose from work supported by grants to Duke University from the National Cancer Institute, the National Science Foundation, and the Wallace H. Coulter Foundation.  In 2007, Oncoscope received exclusive, worldwide license rights from Duke University to a/LCI optical imaging technology and began developing clinical prototypes. In parallel, work continued at Duke University including animal and human clinical testing of a/LCI in esophageal tissue. The results of the first pilot study of 30 patients were presented in May 2009 at Digestive Disease Week in Chicago, IL.